Sorafenib/SBRT Yields OS Benefit in Locally Advanced Hepatocellular Carcinoma

被引：0
|
作者：
Seymour, Caroline
机构：
来源：
ONCOLOGY-NEW YORK | 2023年 / 37卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：148 / 148
页数：1
相关论文
共 50 条
  • [31] Benefit-Risk Summary of Regorafenib for the Treatment of Patients with Advanced Hepatocellular Carcinoma That Has Progressed on Sorafenib
    Pelosof, Lorraine
    Lemery, Steven
    Casak, Sandra
    Jiang, Xiaoping
    Rodriguez, Lisa
    Pierre, Vadryn
    Bi, Youwei
    Liu, Jiang
    Zirkelbach, Jeanne Fourie
    Patel, Anuja
    Goldberg, Kirsten B.
    McKee, Amy E.
    Keegan, Patricia
    Pazdur, Richard
    ONCOLOGIST, 2018, 23 (04): : 496 - 500
  • [32] Additive Benefit of Transarterial Chemoembolization and Sorafenib in Treating Advanced-Stage Hepatocellular Carcinoma: Propensity analysis
    Choi, Gwang Hyeon
    Shim, Ju Hyun
    Lee, Danbi
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Chung, Young-Hwa
    Lee, Yung Sang
    Suh, Dong Jin
    Kang, Yoon-Koo
    HEPATOLOGY, 2012, 56 : 469A - 469A
  • [33] Phase II trial of sorafenib with capecitabine and oxaliplatin (SECOX) in patients with locally advanced or metastatic hepatocellular carcinoma
    Yau, T.
    Chan, P.
    Cheung, F. Y.
    Lee, A. S.
    Yau, T. K.
    Choo, S. P.
    Lau, J.
    Wong, J. S.
    Fan, S. T.
    Poon, R. T.
    EJC SUPPLEMENTS, 2009, 7 (03): : 20 - 21
  • [34] Late-onset benefit in progressive advanced hepatocellular carcinoma with continued sorafenib therapy: A case report
    Okuwaki Y.
    Nakazawa T.
    Hidaka H.
    Shibuya A.
    Koizumi W.
    Journal of Medical Case Reports, 6 (1)
  • [35] Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S).
    Meyers, Daniel E.
    Lee-Ying, Richard M.
    Alghamdi, Mohammed Abdullah
    Cheung, Winson Y.
    Samawi, Haider
    Tam, Vincent C.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [36] Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
    Gauthier, Angela
    Ho, Mitchell
    HEPATOLOGY RESEARCH, 2013, 43 (02) : 147 - 154
  • [37] SORAFENIB VERSUS CAPECITABINE IN THE MANAGEMENT OF ADVANCED HEPATOCELLULAR CARCINOMA
    Abdelwahab, M.
    Shaker, M.
    Abdelwahab, S.
    Elbassiouny, M.
    Ellithy, M.
    Abdelrhman, O.
    ANNALS OF ONCOLOGY, 2012, 23 : 253 - 253
  • [38] Looking Beyond Sorafenib to Treat Advanced Hepatocellular Carcinoma
    Agrawal, Swastik
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2016, 6 (04) : 339 - 342
  • [39] Sorafenib versus capecitabine in the management of advanced hepatocellular carcinoma
    Omar Abdel-Rahman
    Manal Abdel-Wahab
    Mohammed Shaker
    Sherif Abdel-Wahab
    Mohammed Elbassiony
    Mahmoud Ellithy
    Medical Oncology, 2013, 30
  • [40] Advanced hepatocellular carcinoma treated by a combination of sorafenib and radiotherapy
    Yang, Bi-Ling
    Yeh, Chun
    Hsu, Chung-Te
    Chang, Tien-Yu
    Wang, Chung-Yih
    ADVANCES IN DIGESTIVE MEDICINE, 2014, 1 (01) : 25 - 29
12345